Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001437749-23-016278
Filing Date
2023-05-31
Accepted
2023-05-31 16:31:33
Documents
19

Document Format Files

Seq Description Document Type Size
1 FORM S-1 nby20230525c_s1.htm   iXBRL S-1 546831
2 EXHIBIT 5.1 ex_527860.htm EX-5.1 16883
3 EXHIBIT 23.1 ex_528026.htm EX-23.1 2802
4 EXHIBIT FILING FEES ex_526772.htm EX-FILING FEES 18713
9 ex_527860img001.jpg GRAPHIC 4215
10 nby20230525c_s1img001.jpg GRAPHIC 5824
11 nby20230525c_s1img002.jpg GRAPHIC 6755
  Complete submission text file 0001437749-23-016278.txt   795964

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA nby-20230531.xsd EX-101.SCH 3593
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20230531_def.xml EX-101.DEF 8202
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20230531_lab.xml EX-101.LAB 10806
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20230531_pre.xml EX-101.PRE 7863
13 EXTRACTED XBRL INSTANCE DOCUMENT nby20230525c_s1_htm.xml XML 1922
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

EIN.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-272297 | Film No.: 23981439
SIC: 2834 Pharmaceutical Preparations